The role of endogenous inhibitors of nitric oxide on glucose homeostasis
Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthases. ADMA is metabolised by dimethylarginine dimethylaminohydrolase (DDAH) of which there are two isoforms with the same catalytic activity but different tissue expression patterns. Clinically ADMA is relevant as inc...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.656777 |